CervoMed Inc. — Director's Dealing 2014

Jul 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RestorGenex Corp (RESX)
CIK: 0001053691
Period of Report: 2014-07-24

Reporting Person: Boris Timothy (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-24	Stock Option (right to buy)	$3.92	A	79655	Acquired	2024-07-24	Common Stock (79655)	Direct

Footnotes

F1: The option will vest in equal quarterly installments for three years following the date of grant of July 24, 2014.